Tue, Jul 7, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 0.19% in March hedge funds up 5.69% in first quarter

Monday, April 16, 2012
Opalesque Industry Update: Hedge funds gained 0.19% in March, according to the Barclay Hedge Fund Index compiled by BarclayHedge.

“The US equity market extended its unbroken rally to four months in March, while European and Asian stock markets were mostly weaker,” says Sol Waksman, founder and president of BarclayHedge.

In March, 15 of Barclay’s 18 hedge fund indices had gains. The Healthcare & Biotechnology Index gained 1.88%, Technology was up 1.84%, Equity Long Bias gained 1.35%, and Equity Market Neutral added 0.80%.

On the negative side, the Emerging Markets Index dropped 1.22% in March, Global Macro gave up 0.39%, and Equity Short Bias lost 0.06%.

“After a 5.48 percent loss in 2011, the Barclay Hedge Fund Index is up 5.69 percent in the first quarter of 2012,” says Waksman.

“Strong performance by hedge fund managers successfully navigating the equity market rally has helped fuel this reversal.”

At the end of the first quarter, Equity Long Bias leads all hedge fund strategies with a 9.41% gain.

“This is the strongest start for long-biased managers in 14 years. The best first quarter for Equity Long Bias was a 10.22 percent gain back in 1998.”

After three months, the Emerging Markets Index is up 7.68%, European Equities gained 7.19%, Healthcare & Biotechnology added 7.18%, Pacific Rim Equities are up 7.05%, and the Technology Index gained 5.96%.

The only losing hedge fund strategy in 2012 is Equity Short Bias, which is down 15.66% at the end of March.

The Barclay Fund of Funds Index gained 0.48% in March, and is up 3.58% in the first quarter.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner